Clinical Trial Update: A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ESO-101 in eosinophilic esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• ESO-101

Snippet

Sponsor: EsoCap AG | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED